- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Algorae Pharmaceuticals Ltd (1AI)
Track today's live Algorae Pharmaceuticals (1AI) share price, performance and key data on this page with our current Sydney:1AI stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Algorae Pharmaceuticals share price on the Sydney exchange. Use the dropdown to switch exchange for the 1AI share price, head to our technical summary section, which provides analysis on Algorae Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Algorae Pharmaceuticals (1AI) stock price today with other investors in the Algorae Pharmaceuticals ASX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ASX:1AI share price (ISIN: AU0000296022) to enhance your trading decisions with our free investment tools and resources.
What Is the Algorae Pharmaceuticals Ltd Share Price Today?
The Algorae Pharmaceuticals share price today is 0.009.
What Is the Stock Symbol for Algorae Pharmaceuticals Ltd
The stock symbol (or 'ticker') for Algorae Pharmaceuticals Ltd is "1AI."
What Stock Exchange Does Algorae Pharmaceuticals Ltd Trade On?
Algorae Pharmaceuticals Ltd is listed and trades on the Sydney stock exchange.
Is Algorae Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Algorae Pharmaceuticals (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current ASX:1AI share price (ISIN: AU0000296022) to enhance your trading decisions with our free investment tools and resources.
What Is the Algorae Pharmaceuticals Ltd Share Price Today?
The Algorae Pharmaceuticals share price today is 0.009.
What Is the Stock Symbol for Algorae Pharmaceuticals Ltd
The stock symbol (or 'ticker') for Algorae Pharmaceuticals Ltd is "1AI."
What Stock Exchange Does Algorae Pharmaceuticals Ltd Trade On?
Algorae Pharmaceuticals Ltd is listed and trades on the Sydney stock exchange.
Is Algorae Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Algorae Pharmaceuticals (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
0.009
0.000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.009
0.010
52 wk Range
0.008
0.024
1AI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0090.010
52 wk Range
0.0080.024
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1AI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Earnings
Latest Release
31/08/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare 1AI to Peers and Sector
Metrics to compare | 1AI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1AIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.7x | −3.6x | −0.4x | |
PEG Ratio | 0.03 | 0.01 | 0.00 | |
Price/Book | 4.3x | 3.1x | 2.6x | |
Price / LTM Sales | - | 17.8x | 3.1x | |
Upside (Analyst Target) | - | 294.7% | 54.8% | |
Fair Value Upside | Unlock | −10.1% | 7.6% | Unlock |
Algorae Pharmaceuticals Limited, an AI-enabled pharmaceutical development company, engages in the research and development of living cells technologies primarily in Australia and New Zealand. The company’s product pipeline includes AI-116, a novel combination drug candidate made up of donepezil and cannabidiol for the treatment of dementia, including Alzheimer’s disease; AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient for the treatment of cardiovascular disease, such as hypertension; and NTCELL, an alginate coated capsule product for the treatment of Parkinson’s disease. It is also developing AlgaraeOS in partnership with the University of New South Wales, a drug discovery platform that uses artificial intelligence protocols and big data analytics for drug discovery and development; and AlgoraeRx, a commercial pharmaceutical division that source generic and specialty medicines from manufacturers. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. Algorae Pharmaceuticals Limited was founded in 1987 and is based in Melbourne, Australia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Algorae Pharmaceuticals (Sydney: 1AI) Share Price Today?
The Algorae Pharmaceuticals stock price today is 0.009 AUD.
What Stock Exchange Does Algorae Pharmaceuticals (1AI) Trade On?
Algorae Pharmaceuticals is listed and trades on the Sydney Stock Exchange.
What Is the Ticker (Stock Symbol) for Algorae Pharmaceuticals?
The stock symbol (also called a 'ticker') for Algorae Pharmaceuticals is "1AI."
What Is the Current Algorae Pharmaceuticals Market Capitalisation?
As of today, Algorae Pharmaceuticals (Sydney: 1AI) market cap is 18.250M AUD.
What Is Algorae Pharmaceuticals's (1AI) Earnings Per Share (TTM)?
The Algorae Pharmaceuticals EPS is currently -0.002 (Trailing Twelve Months).
Is 1AI a Buy or Sell From a Technical Analyst Perspective?
Based on today's Algorae Pharmaceuticals moving averages and other technical indicators, the daily buy/sell signal for 1AI stock is Strong Sell.
How Many Times Has Algorae Pharmaceuticals Stock Split?
Algorae Pharmaceuticals has split 0 times. (See the 1AI stock split history page for full effective split date and price information.)
How Many Employees Does Algorae Pharmaceuticals Have?
Algorae Pharmaceuticals has 48 employees, based on their latest Companies House report.
What is the current trading status of Algorae Pharmaceuticals (Sydney: 1AI)?
As of 30/09/2026, Algorae Pharmaceuticals (1AI) is trading at a share price of 0.009 AUD, with a previous close of 0.009 AUD. The stock has fluctuated within a day range of 0.009 AUD to 0.010 AUD, while its 52-week range spans from 0.008 AUD to 0.024 AUD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.